Pathos AI has launched a $400 million funding round and already raised nearly $283 million. The Chicago-based startup formed ...

Tempus AI is a leader in applying AI solutions to cancer diagnosis. The company announced a new platform for speeding up the ...

On CNBC's "Mad Money Lightning Round," Jim Cramer recommended buying BlackRock, Inc. because "it's going to be a great position." ...

Clearfield County is a small step closer to being able to sue the architect and contractors who made a critical error in the design and construction of the county prison, which opened in 1981. That ...

BlackRock, Tempus, Sunrun, EXL Service, Union Pacific and VieMed Healthcare.

Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...

The EDA trio—Cadence, Siemens EDA, and Synopsys—was prominent at the Intel Foundry Direct Connect 2025 while lining up ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Tempus Ai wasn’t one of them. The 10 stocks that made the cut could ...

ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the“Company”) recently announced U.S. FDA approval of its innovative yield enhancement production process. This innovative process has demonstrated an ...

FN Media Group News Commentary - According to reports from industry insiders the Global AI in Diabetic Retinopathy market is projected to continue to grow at a substantial rate for years to come.